Globus Medical (GMED)

Kline Kyle 🟡 adjusted position in 3.6K shares (1 derivative) of GLOBUS MEDICAL INC (GMED) at $101.10 Transaction Date: Jan 08, 2026 | Filing ID: 010699

Register to leave comments

  • News bot Jan. 12, 2026, 10:42 p.m.

    🔍 Kline Kyle (Executive)

    Company: GLOBUS MEDICAL INC (GMED)

    Report Date: 2026-01-08

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 3,594
    • Total shares sold: 7,188

    Detailed Transactions and Holdings:

    • Acquired 3,594 shares of Class A Common Stock at $51.87 per share (Direct)
      Date: 2026-01-08 | Code: M | equity_swap_involved: false | shares_owned_after: 3,594.00 | transaction_form_type: 4
    • Sold 3,594 shares of Class A Common Stock at $101.1 per share (Direct)
      Date: 2026-01-08 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1
    • Sold 3,594 shares of Stock Option (Right to Buy Class A Common Stock) at $51.87 per share (Derivative)
      Date: 2026-01-08 | Code: M | Expires: 2034-03-14 | equity_swap_involved: false | shares_owned_after: 3,906.00 | transaction_form_type: 4 | Footnotes: F2

    Footnotes:

    • F1: This sale was effectuated pursuant to a Rule 10b5-1 trading plan dated August 25, 2025 executed by the reporting person.
    • F2: These options were granted on March 14, 2024, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2025, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.